AKT1 and non-small cell lung carcinoma: MiR-128 were significantly downregulated in NSCLC tissues and cells, overexpressed MiR-128significantly curbed VEGF-C expression, which in turn restricted VEGFR-3-induced activation of ERK, p38, and AKT signaling pathways [85].